Skip to main content
Livermore
Livermore
ZHEN

Millennium Management LLC

SEC CIK
0001273087
Latest filing
Aug 14, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Millennium Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
316,001
Value
$95.1M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of ALNY by Millennium Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026316,001$95.1M0.1%−131,886−29.4%ReducedHolders
Q1 2026447,887$148.2M0.1%+372,457+493.8%AddedHolders
Q4 202575,430$30.0M<0.1%−474,501−86.3%ReducedHolders
Q3 2025549,931$250.8M0.2%+459,486+508.0%AddedHolders
Q2 202590,445$29.5M<0.1%−196,892−68.5%ReducedHolders
Q1 2025287,337$77.6M0.1%−46,105−13.8%ReducedHolders
Q4 2024333,442$78.5M0.1%+82,479+32.9%AddedHolders
Q3 2024250,963$69.0M0.1%+112,459+81.2%AddedHolders
Q2 2024138,504$33.7M<0.1%−63,774−31.5%ReducedHolders
Q1 2024202,278$30.2M<0.1%+165,742+453.6%AddedHolders
Q4 202336,536$6.99M<0.1%+20,429+126.8%AddedHolders
Q3 202316,107$2.85M<0.1%−58,873−78.5%ReducedHolders
Q2 202374,980$14.2M<0.1%+51,606+220.8%AddedHolders
Q1 202323,374$4.68M<0.1%+23,374NewHolders
Q4 20220$00.0%−172,770−100.0%Sold outHolders
Q3 2022172,770$34.6M<0.1%+168,318+3,780.7%AddedHolders
Q2 20224,452$649.0K<0.1%−59,505−93.0%ReducedHolders
Q1 202263,957$10.4M<0.1%−19,460−23.3%ReducedHolders
Q4 202183,417$14.1M<0.1%+71,585+605.0%AddedHolders
Q3 202111,832$2.23M<0.1%+1,711+16.9%AddedHolders
Q2 202110,121$1.72M<0.1%−65,659−86.6%ReducedHolders
Q1 202175,780$10.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.